296 related articles for article (PubMed ID: 34728290)
21. A randomized, controlled trial of the effectiveness of cognitive-behavioral therapy and sertraline versus a waitlist control group for anxiety disorders in older adults.
Schuurmans J; Comijs H; Emmelkamp PM; Gundy CM; Weijnen I; van den Hout M; van Dyck R
Am J Geriatr Psychiatry; 2006 Mar; 14(3):255-63. PubMed ID: 16505130
[TBL] [Abstract][Full Text] [Related]
22. Adjunctive sleep medications and depression outcome in the treatment of serotonin-selective reuptake inhibitor resistant depression in adolescents study.
Shamseddeen W; Clarke G; Keller MB; Wagner KD; Birmaher B; Emslie GJ; Ryan N; Asarnow JR; Porta G; Brent DA
J Child Adolesc Psychopharmacol; 2012 Feb; 22(1):29-36. PubMed ID: 22251024
[TBL] [Abstract][Full Text] [Related]
23. Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
Rosnick CB; Wetherell JL; White KS; Andreescu C; Dixon D; Lenze EJ
J Consult Clin Psychol; 2016 Apr; 84(4):345-52. PubMed ID: 26881447
[TBL] [Abstract][Full Text] [Related]
24. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
[TBL] [Abstract][Full Text] [Related]
25. Switching Selective Serotonin Reuptake Inhibitors in Adolescents with Selective Serotonin Reuptake Inhibitor-Resistant Major Depressive Disorder: Balancing Tolerability and Efficacy.
Strawn JR; Mills JA; Croarkin PE
J Child Adolesc Psychopharmacol; 2019 May; 29(4):250-255. PubMed ID: 30810350
[No Abstract] [Full Text] [Related]
26. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
[TBL] [Abstract][Full Text] [Related]
27. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sample.
Vitiello B; Emslie G; Clarke G; Wagner KD; Asarnow JR; Keller MB; Birmaher B; Ryan ND; Kennard B; Mayes TL; DeBar L; Lynch F; Dickerson J; Strober M; Suddath R; McCracken JT; Spirito A; Onorato M; Zelazny J; Porta G; Iyengar S; Brent DA
J Clin Psychiatry; 2011 Mar; 72(3):388-96. PubMed ID: 21208583
[TBL] [Abstract][Full Text] [Related]
29. Emotion-based brain mechanisms and predictors for SSRI and CBT treatment of anxiety and depression: a randomized trial.
Gorka SM; Young CB; Klumpp H; Kennedy AE; Francis J; Ajilore O; Langenecker SA; Shankman SA; Craske MG; Stein MB; Phan KL
Neuropsychopharmacology; 2019 Aug; 44(9):1639-1648. PubMed ID: 31060042
[TBL] [Abstract][Full Text] [Related]
30. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial.
Misri S; Reebye P; Corral M; Milis L
J Clin Psychiatry; 2004 Sep; 65(9):1236-41. PubMed ID: 15367052
[TBL] [Abstract][Full Text] [Related]
31. Symptom clusters in adolescent depression and differential response to treatment: a secondary analysis of the Treatment for Adolescents with Depression Study randomised trial.
Bondar J; Caye A; Chekroud AM; Kieling C
Lancet Psychiatry; 2020 Apr; 7(4):337-343. PubMed ID: 32199509
[TBL] [Abstract][Full Text] [Related]
32. Child/Adolescent anxiety multimodal study: evaluating safety.
Rynn MA; Walkup JT; Compton SN; Sakolsky DJ; Sherrill JT; Shen S; Kendall PC; McCracken J; Albano AM; Piacentini J; Riddle MA; Keeton C; Waslick B; Chrisman A; Iyengar S; March JS; Birmaher B
J Am Acad Child Adolesc Psychiatry; 2015 Mar; 54(3):180-90. PubMed ID: 25721183
[TBL] [Abstract][Full Text] [Related]
33. [The effect of antidepressants and sedatives on the efficacy of transdiagnostic cognitive behavioral therapy in groups in primary care].
Eriksson EB; Kristjansdottir H; Sigurdsson JF; Agnarsdottir A; Sigurdsson E
Laeknabladid; 2013 Nov; 99(11):505-10. PubMed ID: 24287740
[TBL] [Abstract][Full Text] [Related]
34. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
[TBL] [Abstract][Full Text] [Related]
35. Is a combined therapy more effective than either CBT or SSRI alone? Results of a multicenter trial on panic disorder with or without agoraphobia.
van Apeldoorn FJ; van Hout WJ; Mersch PP; Huisman M; Slaap BR; Hale WW; Visser S; van Dyck R; den Boer JA
Acta Psychiatr Scand; 2008 Apr; 117(4):260-70. PubMed ID: 18307586
[TBL] [Abstract][Full Text] [Related]
36. Internet-Delivered Cognitive Behavioural Therapy for Major Depression and Anxiety Disorders: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2019; 19(6):1-199. PubMed ID: 30873251
[TBL] [Abstract][Full Text] [Related]
37. The Relationship Between Plasma Cytokine Levels and Response to Selective Serotonin Reuptake Inhibitor Treatment in Children and Adolescents with Depression and/or Anxiety Disorders.
Amitai M; Taler M; Carmel M; Michaelovsky E; Eilat T; Yablonski M; Orpaz N; Chen A; Apter A; Weizman A; Fennig S
J Child Adolesc Psychopharmacol; 2016 Oct; 26(8):727-732. PubMed ID: 26771135
[TBL] [Abstract][Full Text] [Related]
38. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
March J; Silva S; Vitiello B;
J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
[TBL] [Abstract][Full Text] [Related]
39. Comparative efficacy, acceptability, and safety of medicinal, cognitive-behavioral therapy, and placebo treatments for acute major depressive disorder in children and adolescents: a multiple-treatments meta-analysis.
Ma D; Zhang Z; Zhang X; Li L
Curr Med Res Opin; 2014 Jun; 30(6):971-95. PubMed ID: 24188102
[TBL] [Abstract][Full Text] [Related]
40. Comparative effectiveness of cognitive behavioral treatment, serotonin, and serotonin noradrenaline reuptake inhibitors for anxiety in children and adolescents: a network meta-analysis.
Arnardóttir A; Skarphedinsson G
Nord J Psychiatry; 2023 Feb; 77(2):118-126. PubMed ID: 35507829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
